Selon yon rap\u00f2 Komite En\u00e8ji ak Kom\u00e8s Chanm Reprezantan Etazini an te f\u00e8 an 2012, l\u00e8 envestigat\u00e8 Komite a te kontakte yo, 90% nan anplwaye salon bwonzaj yo te bay fo enf\u00f2masyon sou risk grav bwonzaj andedan kay la epi yo te f\u00e8 fo deklarasyon sou benefis sante ke bwonzaj andedan kay la bay (<\/span> AAD<\/span><\/a> ).<\/span><\/p>\n\n Nan lemonnantye, gen plis ka kans\u00e8 po ak\u00f2z bronzaj andedan kay la pase ka kans\u00e8 nan poumon ak\u00f2z fimen (<\/span> SCF<\/span><\/a> ). Ajans Ent\u00e8nasyonal pou Rech\u00e8ch sou Kans\u00e8 (IARC) te klase kabann bronzaj yo nan kategori ki gen pi gwo risk kans\u00e8: kanseroj\u00e8n pou moun (<\/span> FDA<\/span><\/a> ).<\/span> Kit li f\u00e8t dey\u00f2 oswa andedan kay la, bronzaj se yon siy vizy\u00e8l domaj ADN nan po ou. Bronzaj koze pa ekspozisyon a radyasyon iltravyol\u00e8t (UV) epi li domaje kouch selil po ki pi ekst\u00e8n yo. Pa gen bagay ki rele yon “bronzaj ki an sekirite” oswa “bronzaj ki bon pou sante” (<\/span> AAD<\/span><\/a> ). Gen yon kantite pr\u00e8v k ap grandi ki endike ke bronzaj ka kreye dejwe. Pami fanm blan ki gen ant 18 ak 30 an ki itilize bronzaj andedan kay la, 20% montre siy dejwe (<\/span> AAD<\/span><\/a> ).<\/span><\/p>\n\n Dapre Fondasyon Kans\u00e8 Po a, gen yon risk 75% ogmante pou devlope melanom ki menase lavi a av\u00e8k yon s\u00e8l sesyon bronzaj andedan kay la anvan laj 35 an (<\/span> SCF<\/span><\/a> ). Bronzaj ogmante tou risk ou genyen pou karsinom selil bazal ak karsinom selil skameuz.<\/span><\/p>\n\n Rezilta etid sou b\u00e8t yo jeneralman sip\u00f2te obs\u00e8vasyon ki soti nan etid epidemyolojik yo ke ekspozisyon UV asosye av\u00e8k risk kans\u00e8 po (<\/span> Gober et al.<\/span><\/a> ).<\/span> <\/p>\n\n Gwoup 1 (kanseroj\u00e8n pou moun: kabann bwonzaj ki em\u00e8t UV)<\/span><\/p>\n\n Evite bronze n\u00e8t se pi bon fason pou pwoteje kont domaj po. Si ou toujou vle aparans lan, gen anpil losyon ki bay yon aparans bronz san ajoute sol\u00e8y. <\/span> Si w ap pase tan nan sol\u00e8y la, s\u00e8vi ak pwoteksyon kont sol\u00e8y; li pa janm tw\u00f2 ta pou k\u00f2manse pwoteje po w. Le pli vit ke ou sispann bronze, k\u00f2 w k\u00f2manse repare k\u00e8k nan domaj ki koze pa reyon UV yo (<\/span> AAD<\/span><\/a> ).<\/span> L\u00e8 w ap chwazi yon kr\u00e8m pwot\u00e8j kont sol\u00e8y, asire w ke etik\u00e8t la di spectre laj, SPF 30 oswa plis, epi reziste dlo. Spectre laj vle di ke kr\u00e8m pwot\u00e8j kont sol\u00e8y la ka pwoteje po w kont reyon UVA ak UVB, epi rezistans dlo vle di ke kr\u00e8m pwot\u00e8j kont sol\u00e8y la ap rete sou po mouye oswa ki swe pandan ant 40 ak 80 minit (<\/span> AAD<\/span><\/a> ).<\/span><\/p>\n\n Bwonzaj andedan kay la (osi byen ke bwonzaj dey\u00f2) ogmante risk pou ou devlope kans\u00e8 po, tankou melanom, karsinom selil bazal, ak karsinom selil skameuz, epi ou ta dwe evite li.<\/p>\n\n Gade ti videyo sa a sou kabann bwonzaj ak risk kans\u00e8 nan Sant Kans\u00e8 MD Anderson an, epi swiv lyen ki anba yo pou plis enf\u00f2masyon.<\/p>\n\nSa syans di nou<\/h2>\n\n
Pr\u00e8v Epidemyolojik<\/h3>\n\n
Pr\u00e8v Laboratwa \/ Pr\u00e8v Sip\u00f2tif<\/h3>\n\n
Klasifikasyon kanseroj\u00e8n IARC: <\/span><\/h3>\n\n
Kijan pou diminye risk ou<\/h2>\n\n
Liy final la<\/h2>\n\n
Sous ak lyen pou plis enf\u00f2masyon<\/h2>\n\n